An overview of epigenetics and chemoprevention

FEBS Letters

Volumn 585, Issue 13, 2011, Pages 2129-2136

  Huang, Yi Wen ^a   Kuo, Chieh Ti ^b   Stoner, Kristen ^b   Huang, Tim H Y ^a   Wang, Li Shu ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer prevention; DNA methylation; Epigenome

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; APC PROTEIN; AZACITIDINE; CADHERIN; CADHERIN 13; CAFFEIC ACID; CARMUSTINE; CATECHOL METHYLTRANSFERASE; CHLOROGENIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; EPIGALLOCATECHIN GALLATE; GENISTEIN; HISTONE DEACETYLASE; HYDRALAZINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MG 98; PANOBINOSTAT; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID; ROMIDEPSIN; TAMOXIFEN; TEMOZOLOMIDE; TRANSCRIPTION FACTOR PITX2; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VORINOSTAT;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER RECURRENCE; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; DIETARY INTAKE; DISEASE COURSE; DNA METHYLATION; DRUG TARGETING; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; EPIGENETICS; GENE MUTATION; GENETIC REGULATION; GLIOBLASTOMA; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN GENETICS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; MYELODYSPLASTIC SYNDROME; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METHYLATION; RASPBERRY; REVIEW; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

CHEMOPREVENTION; EPIGENOMICS; HUMANS; MODELS, BIOLOGICAL;

EID: 79959820766     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.11.002     Document Type: Review

References (74)

1. K.D. Barbara, V. Mukesh, and U. Asad Epigenetics in cancer prevention: early detection and risk assessment Ann. N.Y. Acad. Sci. 983 2003 1 4
2. S.B. Baylin, and J.E. Ohm Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6 2006 107 116 (Pubitemid 43361543)
3. C.B. Yoo, and P.A. Jones Epigenetic therapy of cancer: past, present and future Nat. Rev. Drug Discov. 5 2006 37 50
4. T. Ushijima, and K. Asada Aberrant DNA methylation in contrast with mutations Cancer Sci. 101 2010 300 305
5. E.N. Gal-Yam, Y. Saito, G. Egger, and P.A. Jones Cancer epigenetics: modifications, screening, and therapy Annu. Rev. Med. 59 2008 267 280 (Pubitemid 351287937)
6. T.H. Huang, and M. Esteller Chromatin remodeling in mammary gland differentiation and breast tumorigenesis Cold Spring Harb. Perspect. Biol. 2 2010 a004515
7. T. Ushijima Detection and interpretation of altered methylation patterns in cancer cells Nat. Rev. Cancer 5 2005 223 231 (Pubitemid 40314953)
8. J.G. Herman, and S.B. Baylin Gene silencing in cancer in association with promoter hypermethylation N. Engl. J. Med. 349 2003 2042 2054 (Pubitemid 37448928)
9. S.B. Baylin Mechanisms underlying epigenetically mediated gene silencing in cancer Semin. Cancer Biol. 12 2002 331 337
10. L. Lopez-Serra, E. Ballestar, M.F. Fraga, M. Alaminos, F. Setien, and M. Esteller A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer Cancer Res. 66 2006 8342 8346 (Pubitemid 44449141)
11. O. Sansom, K. Maddison, and A. Clarke Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer Nat. Clin. Pract. Oncol. 4 2007 301 315
12. A.G. Knudson Two genetic hits (more or less) to cancer Nat. Rev. Cancer 1 2001 157 162 (Pubitemid 33741891)
13. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428 (Pubitemid 34587077)
14. T. Maekita, K. Nakazawa, M. Mihara, T. Nakajima, K. Yanaoka, M. Iguchi, K. Arii, A. Kaneda, T. Tsukamoto, M. Tatematsu, G. Tamura, D. Saito, T. Sugimura, M. Ichinose, and T. Ushijima High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk Clin Cancer Res. 12 2006 989 995 (Pubitemid 43259882)
15. M. Dhir, E.A. Montgomery, S.C. Glöckner, K.E. Schuebel, C.M. Hooker, J.G. Herman, S.B. Baylin, S.L. Gearhart, and N. Ahuja Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia J. Gastrointest. Surg. 12 2008 1745 1753
16. N. Ahuja, Q. Li, A.L. Mohan, S.B. Baylin, and J.P. Issa Aging and DNA methylation in colorectal mucosa and cancer Cancer Res. 58 1998 5489 5494 (Pubitemid 28551135)
17. B. Kwabi-Addo, W. Chung, L. Shen, M. Ittmann, T. Wheeler, J. Jelinek, and J.P. Issa Age-related DNA methylation changes in normal human prostate tissues Clin. Cancer Res. 13 2007 3796 3802 (Pubitemid 47037584)
18. S. Maegawa, G. Hinkal, H.S. Kim, L. Shen, L. Zhang, J. Zhang, N. Zhang, S. Liang, L.A. Donehower, and J.P. Issa Widespread and tissue specific age-related DNA methylation changes in mice Genome Res. 20 2010 332 340
19. W.M. Grady, and J.M. Carethers Genomic and epigenetic instability in colorectal cancer pathogenesis Gastroenterology 135 2008 1079 1099
20. B.C. Christensen, E.A. Houseman, G.M. Poage, J.J. Godleski, R. Bueno, D.J. Sugarbaker, J.K. Wiencke, H.H. Nelson, C.J. Marsit, and K.T. Kelsey Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma Cancer Res. 70 2010 5686 5694
21. H. Suzuki, D.N. Watkins, K.W. Jair, K.E. Schuebel, S.D. Markowitz, W.D. Chen, T.P. Pretlow, B. Yang, Y. Akiyama, M. Van Engeland, M. Toyota, T. Tokino, Y. Hinoda, K. Imai, J.G. Herman, and S.B. Baylin Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat. Genet. 36 2004 417 422 (Pubitemid 38437267)
22. A. Gregorieff, and H. Clevers Wnt signaling in the intestinal epithelium: from endoderm to cancer Genes Dev. 19 2005 877 890 (Pubitemid 40548056)
23. L.E. Moore, W.Y. Huang, J. Chung, and R.B. Hayes Epidemiologic considerations to assess altered DNA methylation from environmental exposures in cancer Ann. N.Y. Acad. Sci. 983 2003 181 196 (Pubitemid 36399331)
24. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat. Rev. Cancer 4 2004 143 153 (Pubitemid 38198742)
25. S. Li, S.D. Hursting, B.J. Davis, J.A. McLachlan, and J.C. Barrett Environmental exposure, DNA methylation, and gene regulation Ann. N.Y. Acad. Sci. 983 2003 161 169
26. R.R. Newbold, E.P. Banks, B. Bullock, and W.N. Jefferson Uterine adenocarcinoma in mice treated neonatally with genistein Cancer Res. 61 2001 4325 4328 (Pubitemid 32685752)
27. A.L. Herbst, R.E. Scully, and S.J. Robboy Prenatal diethylstilbestrol exposure and human genital tract abnormalities Natl. Cancer Inst. Monogr. 51 1979 25 35 (Pubitemid 9239325)
28. P.Y. Hsu, D.E. Deatherage, B.A. Rodriguez, S. Liyanarachchi, Y.I. Weng, T. Zuo, J. Liu, A.S. Cheng, and T.H. Huang Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells Cancer Res. 69 2009 5936 5945
29. P.Y. Hsu, H.K. Hsu, G.A. Singer, P.S. Yan, B.A. Rodriguez, J.C. Liu, Y.I. Weng, D.E. Deatherage, Z. Chen, J.S. Pereira, R. Lopez, J. Russo, Q. Wang, C.A. Lamartiniere, K.P. Nephew, and T.H. Huang Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping Genome Res. 20 2010 733 744
30. R.K. Lin, C.Y. Wu, J.W. Chang, L.J. Juan, H.S. Hsu, C.Y. Chen, Y.Y. Lu, Y.A. Tang, Y.C. Yang, P.C. Yang, and Y.C. Wang Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer Cancer Res. 70 2010 5807 5817
31. M.Y. Shah, A. Vasanthakumar, N.Y. Barnes, M.E. Figueroa, A. Kamp, C. Hendrick, K.R. Ostler, E.M. Davis, S. Lin, J. Anastasi, M.M. Le Beau, I.P. Moskowitz, A. Melnick, P. Pytel, and L.A. Godley DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis Cancer Res. 70 2010 5840 5850
32. A. Riccio New endogenous regulators of class I histone deacetylases Sci. Signal. 3 2010 pe1
33. J.P. Issa DNA methylation as a therapeutic target in cancer Clin. Cancer Res. 13 2007 1634 1637
34. D.V. Santi, A. Norment, and C.E. Garrett Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine Proc. Natl Acad. Sci. USA 81 1984 6993 6997 (Pubitemid 15216684)
35. E. Kaminskas, A. Farrell, S. Abraham, A. Baird, L.S. Hsieh, S.L. Lee, J.K. Leighton, H. Patel, A. Rahman, R. Sridhara, Y.C. Wang, R. Pazdur FDA Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes Clin. Cancer Res. 11 2005 3604 3608 (Pubitemid 40685574)
36. J.P. Issa, G. Garcia-Manerom, F.J. Giles, R. Mannari, D. Thomas, S. Faderl, E. Bayar, J. Lyons, C.S. Rosenfeld, J. Cortes, and H.M. Kantarjian Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies Blood 103 2004 1635 1640 (Pubitemid 38268953)
37. J.P. Issa, V. Gharibyan, J. Cortes, J. Jelinek, G. Morris, S. Verstovsek, M. Talpaz, G. Garcia-Manero, and H.M. Kantarjian Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate J. Clin. Oncol. 23 2005 3948 3956 (Pubitemid 46218698)
38. M. Lubbert, M. Daskalakis, R. Kunzmann, M. Engelhardt, Y. Guo, and P. Wijermans Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2′-deoxycytidine (decitabine) Leuk. Res. 28 2004 1267 1271 (Pubitemid 39314406)
39. P. Zambrano, B. Segura-Pacheco, E. Perez-Cardenas, L. Cetina, A. Revilla-Vazquez, L. Taja-Chayeb, A. Chavez-Blanco, E. Angeles, G. Cabrera, K. Sandoval, C. Trejo-Becerril, J. Chanona-Vilchis, and A. Duenas-González A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes BMC Cancer 5 2005 44
40. A.J. Davis, K.A. Gelmon, L.L. Siu, M.J. Moore, C.D. Britten, N. Mistry, H. Klamut, S. D'Aloisio, M. MacLean, N. Wainman, D. Ayers, P. Firby, J.M. Besterman, G.K. Reid, and E.A. Eisenhauer Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks Invest. New Drugs 21 2003 85 97 (Pubitemid 36628488)
41. E. Raffoux, P. Chaibi, H. Dombret, and L. Degos Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia Haematologica 90 2005 986 988 (Pubitemid 41020306)
42. W.K. Kelly, V.M. Richon, O. O'Connor, T. Curley, B. MacGregor-Curtelli, W. Tong, M. Klang, L. Schwartz, S. Richardson, E. Rosa, M. Drobnjak, C. Cordon-Cordo, J.H. Chiao, R. Rifkind, P.A. Marks, and H. Scher Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously Clin. Cancer Res. 9 2003 3578 3588 (Pubitemid 37169221)
43. F. Giles, T. Fischer, J. Cortes, G. Garcia-Manero, J. Beck, F. Ravandi, E. Masson, P. Rae, G. Laird, S. Sharma, H. Kantarjian, M. Dugan, M. Albitar, and K. Bhalla A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies Clin. Cancer Res. 12 2006 4628 4635 (Pubitemid 44297814)
44. J.C. Byrd, G. Marcucci, M.R. Parthun, J.J. Xiao, R.B. Klisovic, M. Moran, T.S. Lin, S. Liu, A.R. Sklenar, M.E. Davis, D.M. Lucas, B. Fischer, R. Shank, S.L. Tejaswi, P. Binkley, J. Wright, K.K. Chan, and M.R. Grever A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia Blood 105 2005 959 967 (Pubitemid 40170861)
45. E.E. Cameron, K.E. Bachman, S. Myohanen, J.G. Herman, and S.B. Baylin Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat. Genet. 21 1999 103 107 (Pubitemid 29036293)
46. A.R. Sharon Diet and DNA methylation interactions in cancer prevention Ann. N.Y. Acad. Sci. 983 2003 197 207
47. Wang, L.S., Arnold, M., Huang, Y.W., Sardo, C., Seguin, C., Martin, E., Huang, T.H., Riedl, K., Schwartz, S., Frankel, W., Pearl, D., Xu, Y., Winston, J.H. 3rd., Yang, G.Y., Stoner, G.D. (in press) Modulation of genetic and epigenetic biomarkers of colon cancer in humans by black raspberries: a phase I pilot study. Clin. Cancer Res.
48. E. Gilbert, and D. Liu Flavonoids influence epigenetic-modifying enzyme activity: structure-function relationships and the therapeutic potential for cancer Curr. Med. Chem. 17 2010 1756 1768
49. M.Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and C.S. Yang Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Res. 63 2003 7563 7570 (Pubitemid 37466673)
50. Z. Gao, Z. Xu, M.S. Hung, Y.C. Lin, T. Wang, M. Gong, X. Zhi, D.M. Jablon, and L. You Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells Anticancer Res. 29 2009 2025 2030
51. W.J. Lee, J.Y. Shim, and B.T. Zhu Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids Mol. Pharmacol. 68 2005 1018 1030 (Pubitemid 41345793)
52. M. Fang, Z. Jin, Y. Wang, J. Liao, G. Yang, L. Wang, and C. Yang Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines Int. J. Oncol. 26 2005 615 622
53. S. Majid, N. Kikuno, J. Nelles, E. Noonan, Y. Tanaka, K. Kawamoto, H. Hirata, L.C. Li, H. Zhao, S.T. Okino, R.F. Place, D. Pookot, and R. Dahiya Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification Cancer Res. 68 2008 2736 2744 (Pubitemid 351556271)
54. S. Majid, A.A. Dar, A.E. Ahmad, H. Hirata, K. Kawakami, V. Shahryari, S. Saini, Y. Tanaka, A.V. Dahiya, G. Khatri, and R. Dahiya BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer Carcinogenesis 30 2009 662 670
55. W.J. Lee, and B.T. Zhu Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols Carcinogenesis 27 2006 269 277 (Pubitemid 43159879)
56. S.A. Ross Diet and DNA methylation interactions in cancer prevention Ann. N.Y. Acad. Sci. 983 2003 197 207 (Pubitemid 36399332)
57. F. Gaudet, J. Hodgson, A. Eden, L. Jackson-Grusby, J. Dausman, J. Gray, H. Leonhardt, and R. Jaenisch Induction of tumors in mice by genomic hypomethylation Science 300 2003 489 492 (Pubitemid 36444330)
58. Y. Yamada, L. Jackson-Grusby, H. Linhart, A. Meissner, A. Eden, H. Lin, and R. Jaenisch Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis Proc. Natl. Acad. Sci. USA 102 2005 13580 13585 (Pubitemid 41420891)
59. M.R. Estécio, V. Gharibyan, L. Shen, A.E. Ibrahim, K. Doshi, R. He, J. Jelinek, A.S. Yang, P.S. Yan, T.H. Huang, E.H. Tajara, and J.P. Issa LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability PLoS One 2 2007 e399
60. J.C. Figueiredo, M.V. Grau, K. Wallace, A.J. Levine, L. Shen, R. Hamdan, X. Chen, R.S. Bresalier, G. McKeown-Eyssen, R.W. Haile, J.A. Baron, and J.P. Issa Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors Cancer Epidemiol. Biomarkers Prev. 18 2009 1041 1049
61. G.D. Stoner Foodstuffs for preventing cancer: the preclinical and clinical development of berries Cancer Prev. Res. 2 2009 187 194
62. S. Belinsky, K. Nikula, W. Palmisano, R. Michels, G. Saccomanno, E. Gabrielson, S. Baylin, and J. Herman Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis Proc. Natl. Acad. Sci. USA 95 1998 11891 11896
63. M.V. Brock, C.M. Hooker, E. Ota-Machida, Y. Han, M. Guo, S. Ames, S. Glöckner, S. Piantadosi, E. Gabrielson, G. Pridham, K. Pelosky, S.A. Belinsky, S.C. Yang, S.B. Baylin, and J.G. Herman DNA methylation markers and early recurrence in stage I lung cancer N. Engl. J. Med. 358 2008 1118 1128 (Pubitemid 351398486)
64. S. Toyooka, M. Suzuki, R. Maruyama, K.O. Toyooka, K. Tsukuda, Y. Fukuyama, T. Iizasa, M. Aoe, H. Date, T. Fujisawa, N. Shimizu, and A.F. Gazdar The relationship between aberrant methylation and survival in non-small-cell lung cancers Br. J. Cancer 91 2004 771 774 (Pubitemid 39141639)
65. S. Toyooka, K. Matsuo, and A.F. Gazdar DNA methylation in lung cancer N. Engl. J. Med. 358 2008 2513 2514
66. S. Maier, I. Nimmrich, T. Koenig, S. Eppenberger-Castori, I. Bohlmann, A. Paradiso, F. Spyratos, C. Thomssen, V. Mueller, J. Nährig, F. Schittulli, R. Kates, R. Lesche, I. Schwope, A. Kluth, A. Marx, J.W. Martens, J.A. Foekens, M. Schmitt, N. Harbeck European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients - technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group Eur. J. Cancer 43 2007 1679 1686 (Pubitemid 47042374)
67. M. Esteller, J. Garcia-Foncillas, E. Andion, S.N. Goodman, O.F. Hidalgo, V. Vanaclocha, S.B. Baylin, and J.G. Herman Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents N. Engl. J. Med. 343 2000 1350 1354
68. M.E. Hegi, A.C. Diserens, T. Gorlia, M.F. Hamou, N. de Tribolet, M. Weller, J.M. Kros, J.A. Hainfellner, W. Mason, L. Mariani, J.E. Bromberg, P. Hau, R.O. Mirimanoff, J.G. Cairncross, R.C. Janzer, and R. Stupp MGMT gene silencing and benefit from temozolomide in glioblastoma N. Engl. J. Med. 352 2005 997 1003 (Pubitemid 40349502)
69. S.J. Kim, H.S. Kang, S.Y. Jung, S.Y. Min, S. Lee, S.W. Kim, Y. Kwon, K.S. Lee, K.H. Shin, and J. Ro Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues J. Mol. Med. 2010 (Epub ahead of print)
70. S. Ogino, J.A. Meyerhardt, T. Kawasaki, J.W. Clark, D.P. Ryan, M.H. Kulke, P.C. Enzinger, B.M. Wolpin, M. Loda, and C.S. Fuchs CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma Virchows Arch. 450 2007 529 537 (Pubitemid 46676250)
71. O. Hartmann, F. Spyratos, N. Harbeck, D. Dietrich, A. Fassbender, M. Schmitt, S. Eppenberger-Castori, V. Vuaroqueaux, F. Lerebours, K. Welzel, S. Maier, A. Plum, S. Niemann, J.A. Foekens, R. Lesche, and J.W. Martens DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy Clin. Cancer Res. 15 2009 315 323
72. D. Dietrich, M. Krispin, J. Dietrich, A. Fassbender, J. Lewin, N. Harbeck, M. Schmitt, S. Eppenberger-Castori, V. Vuaroqueaux, F. Spyratos, J.A. Foekens, R. Lesche, and J.W. Martens CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients BMC Cancer 10 2010 247
73. M. Mitsuno, Y. Kitajima, T. Ide, K. Ohtaka, M. Tanaka, S. Satoh, and K. Miyazaki Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients J. Gastroenterol. 42 2007 866 873 (Pubitemid 350142766)
74. Y.W. Huang, T. Huang, and L.S. Wang Profiling DNA methylomes from microarray to genome-scale sequencing Technol. Cancer Res. Treat. 9 2010 139 147